ORBIMED ADVISORS LLC – Horizon Therapeutics Public Limited Company Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -2.10M shares | -168.17M | $61.89 | 0 |
| Q2 2022 | share | Decrease | -4.01% | -88K shares | -62.92M | $79.76 | 2.10M |
| Q1 2022 | share | Decrease | -12.14% | -303.5K shares | -38.30M | $105.21 | 2.19M |
| Q4 2021 | share | Decrease | -4.23% | -110.3K shares | -16.53M | $108.26 | 2.50M |
| Q3 2021 | share | Decrease | -10.67% | -311.8K shares | 12.30M | $109.54 | 2.61M |
| Q2 2021 | share | Decrease | -7.07% | -222.2K shares | -15.77M | $93.64 | 2.92M |
| Q1 2021 | share | Increase | +4.51% | 135.6K shares | 69.31M | $92.04 | 3.14M |
| Q4 2020 | share | 0.00% | 0 shares | -13.63M | $73.15 | 3.00M | |
| Q3 2020 | share | Increase | +4.91% | 140.84K shares | 74.32M | $77.68 | 3.00M |
| Q2 2020 | share | Increase | +22.47% | 526.21K shares | 90.03M | $55.58 | 2.86M |
| Q1 2020 | share | Increase | +47.99% | 759.4K shares | 12.08M | $29.62 | 2.34M |
| Q4 2019 | share | Increase | 0.00% | 1.58M shares | 57.27M | $36.2 | 1.58M |